Literature DB >> 7629123

Peroxisome proliferator-activated receptor mediates cross-talk with thyroid hormone receptor by competition for retinoid X receptor. Possible role of a leucine zipper-like heptad repeat.

C E Juge-Aubry1, A Gorla-Bajszczak, A Pernin, T Lemberger, W Wahli, A G Burger, C A Meier.   

Abstract

The peroxisome proliferator-activated receptors (PPAR) and thyroid hormone receptors (TR) are members of the nuclear receptor superfamily, which regulate lipid metabolism and tissue differentiation. In order to bind to DNA and activate transcription, PPAR requires the formation of heterodimers with the retinoid X receptor (RXR). In addition to activating transcription through its own response elements, PPAR is able to selectively down-regulate the transcriptional activity of TR, but not vitamin D receptor. The molecular basis of this functional interaction has not been fully elucidated. By means of site-directed mutagenesis of hPPAR alpha we mapped its inhibitory action on TR to a leucine zipper-like motif in the ligand binding domain of PPAR, which is highly conserved among all subtypes of this receptor and mediates heterodimerization with RXR. Replacement of a single leucine by arginine at position 433 of hPPAR alpha (L433R) abolished heterodimerization of PPAR with RXR and consequently its trans-activating capacity. However, a similar mutation of a leucine residue to arginine at position 422 showed no alteration of heterodimerization, DNA binding, or transcriptional activation. The dimerization deficient mutant L433R was no longer able to inhibit TR action, demonstrating that the selective inhibitory effect of PPAR results from the competition for RXR as well as possibly for other TR-auxiliary proteins. In contrast, abolition of DNA binding by a mutation in the P-box of PPAR (C122S) did not eliminate the inhibition of TR trans-activation, indicating that competition for DNA binding is not involved. Additionally, no evidence for the formation of PPAR:TR heterodimers was found in co-immunoprecipitation experiments. In summary, we have demonstrated that PPAR selectively inhibits the transcriptional activity of TRs by competition for RXR and possibly non-RXR TR-auxiliary proteins. In contrast, this functional interaction is independent of the formation of PPAR:TR heterodimers or competition for DNA binding.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7629123     DOI: 10.1074/jbc.270.30.18117

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

Review 1.  Peroxisome proliferator-activated receptors: lipid binding proteins controling gene expression.

Authors:  Marc van Bilsen; Ger J van der Vusse; Andries J Gilde; Martijn Lindhout; Karin A J M van der Lee
Journal:  Mol Cell Biochem       Date:  2002-10       Impact factor: 3.396

2.  PPARα in lysosomal biogenesis: A perspective.

Authors:  Arunava Ghosh; Kalipada Pahan
Journal:  Pharmacol Res       Date:  2015-11-24       Impact factor: 7.658

3.  DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita.

Authors:  M Ito; R Yu; J L Jameson
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

4.  A divergent role of COOH-terminal domains in Nurr1 and Nur77 transactivation.

Authors:  S O Castillo; Q Xiao; Z Kostrouch; B Dozin; V M Nikodem
Journal:  Gene Expr       Date:  1998

5.  Ligand-binding regulation of LXR/RXR and LXR/PPAR heterodimerizations: SPR technology-based kinetic analysis correlated with molecular dynamics simulation.

Authors:  Liduo Yue; Fei Ye; Chunshan Gui; Haibin Luo; Jianhua Cai; Jianhua Shen; Kaixian Chen; Xu Shen; Hualiang Jiang
Journal:  Protein Sci       Date:  2005-03       Impact factor: 6.725

6.  Ligand-activated PPARbeta efficiently represses the induction of LXR-dependent promoter activity through competition with RXR.

Authors:  Kimihiko Matsusue; Aya Miyoshi; Shigeru Yamano; Frank J Gonzalez
Journal:  Mol Cell Endocrinol       Date:  2006-08-15       Impact factor: 4.102

7.  Beta-arrestin-1 protein represses adipogenesis and inflammatory responses through its interaction with peroxisome proliferator-activated receptor-gamma (PPARgamma).

Authors:  Le-nan Zhuang; Wen-xiang Hu; Shun-mei Xin; Jian Zhao; Gang Pei
Journal:  J Biol Chem       Date:  2011-06-23       Impact factor: 5.157

8.  Activation of peroxisome proliferator-activated receptor α induces lysosomal biogenesis in brain cells: implications for lysosomal storage disorders.

Authors:  Arunava Ghosh; Malabendu Jana; Khushbu Modi; Frank J Gonzalez; Katherine B Sims; Elizabeth Berry-Kravis; Kalipada Pahan
Journal:  J Biol Chem       Date:  2015-03-06       Impact factor: 5.157

Review 9.  Thyroid hormone crosstalk with nuclear receptor signaling in metabolic regulation.

Authors:  Yan-Yun Liu; Gregory A Brent
Journal:  Trends Endocrinol Metab       Date:  2009-12-16       Impact factor: 12.015

Review 10.  PPARalpha: energy combustion, hypolipidemia, inflammation and cancer.

Authors:  Sean R Pyper; Navin Viswakarma; Songtao Yu; Janardan K Reddy
Journal:  Nucl Recept Signal       Date:  2010-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.